Reduction mammaplasty is one of the most common surgical procedures performed by plastic surgeons in the United States.
of patient satisfaction following the procedure. 8 However, in an era of ever increasing cost-awareness, reduction mammaplasty has also been demonstrated to be a cost-effective means for reducing patient morbidity 9 and has also been suggested as a useful tool for cancer screening in women with macromastia. 10, 11 A variety of techniques for reducing breast volume have been developed since reduction mammaplasty was first introduced in the late 19th century. 12 Complication rates may vary according to the techniques employed for reduction mammaplasty. These commonly include the inferior pedicle 13 and vertical mammaplasty, 14 as well as other modifications. 15, 16 Nevertheless, the benefits of reduction mammaplasty must be weighed against the potential costs of complications. Recent studies have shown that patient age, 17 weight, [18] [19] [20] [21] and smoking status [22] [23] [24] [25] may have an adverse impact on their overall outcomes. Furthermore, intraoperative considerations, including the weight of breast tissue resected 2, 19, 25 and the participation of resident surgical trainees, 24, 26, 27 may affect subsequent patient complications.
Most studies to date have examined relatively small cohorts of women undergoing reduction mammaplasty, often at a single institution by a single or small number of surgeons. We therefore sought to characterize predictors of postoperative complications following reduction mammaplasty based on data from the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) data sets.
MEthods
We identified patients undergoing reduction mammaplasty in the 2005-2010 NSQIP data sets. 28 Deidentified patient information is freely available to all institutional members who comply with the ACS-NSQIP Data Use Agreement. The Data Use Agreement implements the protections afforded by the Health Insurance Portability and Accountability Act (HIPAA) of 1996. The ACS-NSQIP and the hospitals participating in the ACS-NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors of this study. Institutional review board exemption was approved by our institution.
Trained research nurses at participating institutions collect NSQIP data using a systematic sampling of general and vascular surgical procedures. A total of 240 variables are collected for each case encounter, including information on patient demographics, comorbidities, intraoperative factors, and postoperative 30-day morbidity and mortality. To ensure a full 30-day postoperative follow-up period for each encounter, patients are contacted either via a letter or a telephone call. Definitions and further information about each of these variables can be accessed via the ACS-NSQIP website (http://site.acsnsqip.org/). Prior audits have demonstrated a relatively low (1.8%) disagreement rate for program variables. The use of the ACS-NSQIP datasets and its associated variables in plastic surgery has been previously published. [29] [30] [31] [32] [33] We accessed data on October 1, 2012. Patients included in our study were identified using the 2010 Current Procedural Terminology (CPT) code for reduction mammaplasty (19318) . We combined several of the predefined NSQIP variables to characterize our 2 major end points: any surgical complication and major surgical complications. Surgical complications included surgical site infection, wound dehiscence, deep wound infection, and unplanned return to the operating room within 30 days. Major surgical complications were defined as a deep infection and/or unplanned return to the operating room. In addition to the aforementioned variables, we separately characterized patients as obese ( ). Univariate analysis was used to compare patients experiencing complications with those who did not. Patient comorbidities and perioperative risk factors were identified among NSQIP variables, including baseline health characteristics, preoperative laboratory studies, and intraoperative factors, including operative time and the participation of surgical residents. Categorical variables were analyzed using the Pearson χ 2 or Fisher exact test, while continuous variables were examined using the unpaired Student t test or Mann-Whitney tests. After univariate analysis, any variables with a P ≤ .10 were included as independent variables in a stepwise logistic regression analysis, with either any surgical complication or major surgical complications as the dependent variables. All tests were 2-tailed; we defined statistical significance as P < .05. All analyses were performed using STATA IC 11.0 (StataCorp, College Station, Texas).
REsuLts

General
A total of 3538 patients were identified as having undergone reduction mammaplasty during the study period. The demographics of these patients are summarized in Table 1 . Patient comorbidities are summarized in Table 2 . Collectively, the cohort had an average BMI of 31.6 kg/m 2 , with 49.8% of the cohort meeting criteria for obesity. Of these, 29% were class 1, 16.2% class 2, and 10% were class 3 according to World Health Organization (WHO) criteria. 35 Of note, a significant proportion of patients (12.1%) were active smokers. Most patients underwent outpatient surgery (80.5%) with an average operative time of 180 minutes. Most reductions were performed by plastic surgeons (3095, 87.5%) while the remainder were done by general surgeons. Surgical residents participated in 1422 of the cases (40.2%) included in this study.
Surgical Complications
A total of 182 patients (5.1%) experienced surgical complications within 30 days of reduction mammaplasty. The incidence of major complications was 2.1% in the study cohort. The incidence of other medical and surgical complications is summarized in Table 3 .
Patients experiencing surgical complications had a higher average BMI (33.4 vs 31.5 kg/m 2 , P = .001), with a significantly larger proportion of morbidly obese patients (BMI ≥40 kg/m 2 , 18.7% vs 9.6%, P < .001; Tables 4 and 5 ). Patients experiencing complications had higher rates of diabetes (P = .04), smoking (P = .01), chronic obstructive pulmonary disease (COPD; P = .05), hypertension (P = .05), and dyspnea (P = .001) ( Table 5 ). This cohort also had significantly higher American Society of Anesthesiologists (ASA) physical status (P < .001) and slightly longer lengths of hospital stay (0.9 vs 0.8 days, P = .02). Patients experiencing complications were more likely to have had a resident involved in their operation (52.7 vs 39.5%, P < .001; Table 4 ). In addition, we specifically assessed the subgroup of patients experiencing major surgical complications (Tables 6  and 7 ). These patients trended toward having a higher average BMI (32.9 vs 31.6 kg/m 2 , P = .08). Patients with major complications were, however, more likely to be active smokers (P = .001) and more often had a history of dyspnea (P = .03) and transient ischemic attacks (P = .03). These patients again had higher ASA scores (P < .001), longer lengths of stay (P = .04), and longer average operative times (194 vs 180 minutes, P = .04) than patients who did not experience major complications.
Logistic Regression Analysis
A number of risk factors were found to be independently associated with surgical complications: morbid obesity (odds ratio [OR], 2.1; P < .001), active smoking (OR, 1.7; P < .001), history of dyspnea (OR, 2.0; P < .001), and resident participation (OR, 1.8; P = .01). Notable factors that were not significantly associated with surgical complications include inpatient status, diabetes mellitus, alcohol use, COPD, and any cardiovascular risk factors. Factors independently associated with major complications included tobacco use (OR, 2.7; P < .001), dyspnea (OR, 2.6; P < .001), resident participation (OR, 2.1; P < .001), and inpatient surgery (OR, 1.8; P = .01).
discussion
This study examines 30-day complications following reduction mammaplasty in a large cohort of patients identified in the ACS-NSQIP database. The overall rate of surgical complications was relatively low, with 5.1% of patients experiencing a surgical site infection, wound dehiscence, deep wound infection, and/or unplanned return to the Values are presented as number (%) unless otherwise indicated. NSQIP, National Surgery Quality Improvement Program.
operating room within 30 days. A smaller portion of the cohort, 2.1%, experienced 1 of the latter 2 major surgical complications. These rates compare favorably to those in previously published series, but it should be noted that many of these other studies include additional complications not identified in our data set. Most previously published studies examining reduction mammaplasty have reviewed risk factors retrospectively among small cohorts of patients, generally at a single institution. These studies have brought to light a variety of potential risk factors for both major and minor complications following reduction mammaplasty, but the conclusions drawn may be affected by surgeon preferences and techniques. Our study, in contrast, reviewed more than 3500 cases performed at institutions across the country, relying on validated, prospective data. Our findings may therefore be more appropriate for generalization across the population of patients seeking reduction mammaplasty. Several key risk factors were identified in our study. Of particular interest is the identification of a history of dyspnea as an independent risk factor for both overall surgical complications and major surgical complications. Compromised preoperative respiratory function has not been previously established as a risk factor for patients undergoing reduction mammoplasty and may reflect overall health status and be associated with prior smoking histories. Tobacco use has been shown to impair wound healing in a variety of plastic surgery procedures. 24 A significant proportion of our study cohort (12.1%) were active smokers at the time of their reduction mammaplasty. Our study supports findings of other authors 22, 23, 25 identifying smoking as a significant risk factor for complications following this procedure (OR, 1.7; P < .001 for any complication and OR, 2.7; P < .001 for major surgical complications). Smoking has also been shown to be an established risk factor for surgical morbidity in breast reconstruction. [31] [32] [33] These findings, in conjunction with other data suggesting that smoking affects wound healing in a dose-and time-dependent manner, 22 further underscore the need to effectively counsel patients regarding smoking cessation at least 4 weeks before performing an elective operation such as reduction mammaplasty.
Nearly half the patients in our study cohort were obese at the time of surgery (49.8%). When stratified by WHO obesity classification, morbidly obese patients (BMI >40 kg/m 2 ) were more than twice as likely as healthy-weight patients to experience surgical complications (OR, 2.1; P < .001). Despite some data suggesting that BMI does not significantly affect complication rates after reduction mammaplasty, 3, 25, 34 our findings support previously published studies identifying BMI as a predictor of postoperative complications in breast reduction. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 29, 30 Interestingly, obesity did not appear to be an independent risk factor for major surgical complications (deep infection and/or unplanned return to the operating room). The increased rate of overall complications in obese patients in this study may be due to a higher incidence of wound dehiscence and other nonoperative healing problems. Obesity has been shown to have an adverse effect on myofibroblast activity and collagen maturation, 37, 38 both of which are critical factors in healing the long surgical incisions involved in reduction mammaplasty. Because obese patients are at greater risk of experiencing significant complications, particular care must be taken in discussing these concerns preoperatively. Weight loss should be considered as a risk reduction measure prior to undergoing elective reduction mammaplasty.
Patients undergoing inpatient reduction mammaplasty comprised 19.5% of the study cohort. Inpatient surgery was found to be an independent predictor of major postoperative complications (OR, 1.8; P = .01); however, this finding may be confounded by other factors not captured in the NSQIP variables. Furthermore, the presence of inpatient status likely increases the chance that a complication is captured, thereby introducing some selection bias. Several studies have recently reviewed the impact of surgical resident involvement (SRI) in operative procedures. Some studies have suggested that SRI increases major and minor complications in some procedures, 26 and we also identified resident participation as a risk factor for surgical complications following breast reduction (OR, 1.8; P = .01). However, other recent studies examining ACS-NSQIP data have found that when patients are more closely matched to control for possible confounders, SRI does not appear to adversely affect major outcomes, 27 including in plastic surgery procedures. 24 Our study did not control for level of training of residents participating in cases, nor did we match patients to the same degree as these other studies. Had we controlled for these significant confounders, SRI might not have been a strong predictor of complications following breast reduction, although this finding merits further investigation. In summary, approximately 5% of patients undergoing reduction mammaplasty experience significant complications within 30 days of surgery. The key predictors of postoperative complications in our study were primarily modifiable, patient-related risk factors (obesity, tobacco use, and dyspnea). The identification of obesity and active smoking as significant predictors of postoperative complications suggests that surgeons should carefully consider whether to perform breast reductions in this patient population. The information presented in this study will allow surgeons to better risk-stratify patients seeking reduction mammaplasty and may assist in the development of screening tools to better select appropriate candidates.
There are a number of limitations to this study. The ACS-NSQIP database collects patient information for only 30 postoperative days and thus may underestimate the true rate of complications following reduction mammaplasty. In addition, the database does not contain specific information regarding surgical techniques employed for each reduction mammaplasty. We therefore are unable to determine whether the type of pedicle used was a significant factor contributing to the rate of surgical complications; this may be of particular concern in the obese population. 4 Similarly, the weight of resected tissue was not available for analysis and thus could not be explored as a potential factor influencing complication rates. This is particularly important given that recent data have suggested that higher-weight resections increase the risk of complications, 20, 25 without added benefit in terms of postoperative improvement in the patient's symptoms. 2 Only a handful of surgical complications were reviewed in this study. Necrosis of the nipple-areolar complex is one of the most troubling complications following reduction mammaplasty, 21, 25 which again may be of particular concern in the obese population. 4 We were not, however, able to examine data relating to this particular complication. Similarly, most publications examining complications following breast reduction have reviewed not only rates of infection and reoperation but also more detailed complications such as hematoma, 19 seroma, 21 delayed wound healing, 22, 23 and/or hypertrophic scarring. 25 Because the ACS-NSQIP databases do not contain information regarding many of these specific complications, we are not able to comment on the rates or risk factors related to these important concerns.
concLusions
This study represents the largest review to date characterizing postoperative surgical complications following reduction mammaplasty, using prospective data from a validated, multicenter database. We report an overall incidence of complications in 1 in 20 patients and a 1 in 50 incidence of a major surgical complication. We identified several independent risk factors associated with surgical complications, including smoking, obesity, dyspnea, and resident participation. Modifiable factors associated with both surgical complications and major complications, such as obesity, smoking, and respiratory function, present new opportunities to risk-stratify, select, and manage patients seeking reduction mammaplasty.
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